Cuba encouraged by early efficacy results of homegrown COVID-19 vaccine
Cuba's Soberana 2 vaccine candidate has shown 62% efficacy with just two of its three doses, state-run biopharmaceutical corporation BioCubaFarma said on Saturday, citing preliminary data from late phase trials.
Cuba's Soberana 2 vaccine candidate has shown 62% efficacy with just two of its three doses, state-run biopharmaceutical corporation BioCubaFarma said on Saturday, citing preliminary data from late phase trials. Cuba, whose biotech sector https://www.reuters.com/article/uk-health-coronavirus-vaccine-cuba-focus-idUKKBN27S1OZ has exported vaccines for decades, has five vaccine candidates in clinical trials, of which two - Soberana 2 and Abdala - are in late phase trials.
"In a few weeks we should have the results for the efficacy with three doses which we expect will be superior," said Vicente Vérez, director of the state-run Finlay Vaccine Institute, which developed Soberana 2. The news comes as the Caribbean's largest island is facing its worst outbreak since the start of the pandemic in the wake of the arrival of more contagious variants, setting new records of daily coronavirus cases.
The Communist-run country has opted not to import foreign vaccines but rather to rely on its own. Experts say it is a risky bet but if it pays off, Cuba could burnish its scientific reputation, generate much-needed hard currency through exports and strengthen the vaccination drive worldwide. "We know our government has not been able to provide this project all the funding it required, and nonetheless this is a result of global standing," President Miguel Diaz-Canel said at the presentation of the results on state-run television.
Several countries from Argentina and Jamaica to Mexico and Venezuela have expressed an interest in buying Cuba's vaccines. Iran started producing Soberana 2 earlier this year as part of late-phase clinical trials. Cuba's authorities have started administering the experimental vaccines en masse https://www.reuters.com/world/americas/cuba-raises-latam-hopes-it-starts-mass-inoculation-with-own-covid-19-shot-2021-05-12 as part of "intervention studies" they hope will slow the spread of the virus.
Daily cases have halved https://www.reuters.com/world/americas/drop-havana-covid-19-cases-boosts-hopes-cuban-vaccines-working-2021-06-17 in the capital since the start of this vaccination campaign, according to official data, although that may also be due to stricter lockdown measures.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
IFC Invests Up to US$20 M in Grupo Farmanova to Boost Access to Medications in Central America and the Caribbean
Tragedy Strikes in Jamaica with Latest Mass Shooting
Latin America and Caribbean Set to Receive Record Remittances in 2024, Despite Slower Growth
Crown Prince Haakon of Norway Highlights Climate Action, Marine Conservation, and Poverty Reduction During Visit to Jamaica
Kangleipak Communist Party Members Arrested in Manipur Police Crackdown